Segal Trials
Nahimis Flores, MBA, ACRP-CP, currently serves as Regulatory Manager at Segal Trials since November 2019, where responsibilities include hiring, training, and developing regulatory staff, along with conducting performance appraisals. Prior experience includes roles as Lead Regulatory Coordinator and Regulatory Coordinator at Segal Trials, focusing on training, guidance, and facilitating the study start-up process. From November 2011 to November 2019, Nahimis worked at the Transportation Security Administration as a Payroll Administrative Assistant and Transportation Security Officer, managing employee records and ensuring compliance with regulations. A brief research internship at the Center for Digestive Health in August 2019 involved patient interaction, data management, and handling regulatory documentation. Nahimis holds a Master’s degree in Business Administration from Universidad Metropolitana and a Bachelor's degree in Communication and Media Studies from Universidad del Sagrado Corazón.
This person is not in any teams
This person is not in any offices
Segal Trials
1 followers
Segal Trials, founded in 1998, is a privately held network of seven research sites throughout South Florida conducting Phase I-IV research trials with a primary emphasis on psychiatry, neurology, addiction, insomnia, general medicine, healthy volunteers, infectious diseases, vaccines, and women’s health. Staying true to its core values of quality, customer service, advocacy, and patient care, the Segal Trials team of over 110 professionals remains agile and competitive, expanding and growing based on the needs of its sponsors and its patients. Federal law requires that every medication must go through a series of clinical research trials before being approved by the FDA, in addition to being approved by an independent Research Ethics Board. Clinical research trials are critical in the advancement of medicine and making available new and helpful medications. It is Segal Trials’ mission to play an integral role in the advancement process and help millions of people suffering from diseases.